-
Impact of Higher-Valent Pediatric Pneumococcal Vaccines on Antimicrobial Resistant Infections and Antibiotic Prescriptions in Greece
Sep 9, 2025, 16:22 PM -
Unintended Consequences of MFN Pricing: Global Access Risks and Revenue Impact
Sep 9, 2025, 16:22 PM -
Assessment of Oncology Analog HTA Outcomes and Evidence Needs in France and Germany
Sep 9, 2025, 16:22 PM -
Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update
Sep 9, 2025, 16:22 PM -
The Association Between COVID-19 Vaccination and the Healthcare Resource Use Related to COVID-19 in Typical Rural Residents in Japan
Sep 9, 2025, 16:22 PM -
Uncertainty About How to Translate JCA Into National HTA Submissions (EU-4 and Poland): A Systematic Comparison From an Industry Perspective
Sep 9, 2025, 16:22 PM -
Burden of Transfusion in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Results From a Real-World Study in European Countries
Sep 9, 2025, 16:22 PM -
What Is Driving the Increase in Terminated NICE Appraisals?
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Regulatory Divergence in Expedited Oncology Approvals: Evidence, Pathways, and Timelines Across FDA, EMA, TGA, and PMDA
Sep 9, 2025, 16:22 PM -
Real-World Efficacy Outcomes for Patients With Relapsed/Refractory Multiple Myeloma (RRMM) From the Flatiron Health Database
Sep 9, 2025, 16:22 PM -
Heatstroke Is Associated With an Increased Risk of Chronic Headache: A Retrospective Cohort Study in Germany
Sep 9, 2025, 16:22 PM -
Mapping the Measurement Gap: Patient-Reported Outcomes Across the Obesity Care Continuum in the GLP-1 Era
Sep 9, 2025, 16:22 PM -
Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of the First-Line (1L) Treatments of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sep 9, 2025, 16:22 PM -
Turning the Tables: AI Halves Table Extraction Time in HEOR Systematic Reviews
Sep 9, 2025, 16:22 PM -
Assessing Treatment Efficiency Indicated in Rare Diseases: Learning From the CEESP Has Economic Opinions
Sep 9, 2025, 16:22 PM -
Estimating Quality-Adjusted Life Expectancy by Ethnicity for Application in Distributional Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of an Artificial Intelligence Software for Stroke Imaging and Treatment Decisions in NHS Hospitals
Sep 9, 2025, 16:22 PM -
Revisiting the Willingness-to-Pay Threshold in the Czech Republic: Integrating QALY Shortfall to Reflect Disease Severity and Unmet Medical Need
Sep 9, 2025, 16:22 PM -
The Next Frontier in HTA Reviewing the Integration of Artificial Intelligence and Discrete Event Simulation for Resource Modeling
Sep 9, 2025, 16:22 PM -
Enhancing Patient Involvement in European Health Technology Assessment (HTA): From Inconsistent National Practices to Systematic Engagement in Joint Clinical Assessments
Sep 9, 2025, 16:22 PM
